News Releases Year: - Any -202020192018201720162015201420132012 Items per page 102550 02/27/20 Summary ToggleClearside Biomedical to Report Fourth Quarter and Full Year 2019 Financial Results and Provide Corporate Update on Wednesday, March 11, 2020 PDF Version 02/26/20 Summary ToggleClearside Biomedical to Present at Two Upcoming Investor Conferences in March 2020 PDF Version 02/25/20 Summary ToggleClearside Biomedical Pipeline Highlighted in Oral Presentations at the Annual Angiogenesis and Macula Society Meetings PDF Version 02/05/20 Summary ToggleClearside Biomedical Announces Presentations to be Given at Angiogenesis and Macula Society Conferences PDF Version 01/28/20 Summary ToggleBausch Health and Clearside Biomedical Announce Publication of PIVOTAL Phase 3 Data ON XIPERE™ (triamcinolone acetonide suprachoroidal injectable suspension) in Ophthalmology PDF Version 01/06/20 Summary ToggleClearside Biomedical to Present at the 38th Annual J.P. Morgan Healthcare Conference PDF Version 11/13/19 Summary ToggleClearside Biomedical to Present at the Stifel 2019 Healthcare Conference PDF Version 11/06/19 Summary ToggleClearside Biomedical Announces Third Quarter 2019 Financial Results and Provides Corporate Update PDF Version 10/30/19 Summary ToggleClearside Biomedical to Report Third Quarter 2019 Financial Results and Provide Corporate Update on Wednesday, November 6, 2019 PDF Version 10/30/19 Summary ToggleClearside Biomedical Announces Option Exercise by REGENXBIO for Global License for Use of SCS Microinjector™ in AAV Gene Therapy Delivery PDF Version Pagination First page First Previous page Page 2 Current page 3 Page 4 Page 5 Next page Last page Last
